7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                            
      operating activities:
    		                            
      net income
    		-92,725,000 -99,899,000 -95,159,000 -111,006,000 -107,754,000 -102,628,000 -114,985,000 -187,043,000 -86,102,000 -72,771,000 -133,533,000 -139,934,000 -161,994,000 -229,432,000 -123,228,000 -72,311,000 -107,526,000 -97,575,000 -107,358,000 -93,045,000 -71,670,000 -49,739,000 -31,829,000 -22,110,000 -13,090,000 -11,300,000 -21,351,000 -25,272,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                            
      depreciation and amortization
    		9,408,000 10,042,000 10,236,000 10,454,000 10,598,000 10,623,000 10,712,000 10,868,000 11,037,000 10,631,000 10,345,000 10,169,000 9,807,000 8,785,000 7,201,000 6,090,000 5,544,000 5,627,000 5,010,000 4,603,000 4,353,000 3,805,000 3,304,000 3,448,000 2,952,000 2,657,000 2,354,000 2,169,000 
      operating lease costs
    		8,571,000 8,572,000 7,870,000 7,776,000 8,131,000 7,607,000 7,619,000 7,553,000 7,438,000 7,369,000 7,339,000                  
      gain on extinguishment of convertible notes
    		0 0 -13,672,000                          
      stock-based compensation
    		42,808,000 42,462,000 37,757,000 36,366,000 49,769,000 27,235,000 27,041,000 24,320,000 21,819,000 22,354,000 22,266,000 23,703,000 20,639,000 25,544,000 24,799,000 26,857,000 35,016,000 34,507,000 55,069,000 56,762,000 55,198,000 25,815,000 6,338,000 5,072,000 5,485,000 3,215,000 3,182,000 2,563,000 
      unrealized losses on marketable equity securities
    		           -5,437,000                 
      impairment of non-marketable equity securities
    		0 0 5,000,000        5,485,000                  
      interest income received on marketable debt securities
    		0 0 7,677,000                          
      other
    		-335,000 -1,220,000 940,000 -144,000 987,000 733,000 652,000 -1,286,000 6,000    3,000 -1,000 21,000              
      changes in operating assets and liabilities:
    		                            
      accounts receivable
    		14,454,000 -14,310,000 -6,115,000 -21,705,000 12,053,000 -15,957,000 4,220,000 18,000 -2,335,000 -1,654,000 12,349,000 -11,056,000 9,076,000 -10,944,000 13,299,000 -36,908,000 -7,077,000 -5,628,000 5,260,000 -17,044,000 4,687,000 7,073,000 -179,000 -8,297,000 674,000 -11,374,000 11,608,000 -21,050,000 
      inventory
    		-6,428,000 -6,805,000 -6,173,000 1,214,000 -5,314,000 -3,993,000 -1,042,000 15,085,000 -16,504,000 -14,056,000 5,125,000 11,449,000 -3,157,000 -23,281,000 -5,937,000 -5,934,000 1,755,000 2,382,000 -6,160,000 5,015,000 -7,377,000 4,794,000 -9,967,000 -421,000 -584,000 -3,920,000 -1,120,000 -2,061,000 
      prepaid expenses and other current assets
    		-1,331,000 -4,204,000 -3,072,000 1,501,000 -531,000 -3,034,000 -5,627,000 -1,774,000 -1,667,000 2,463,000 -3,354,000 -7,943,000 4,717,000 1,788,000 21,882,000 -29,995,000 -2,722,000 -3,557,000 521,000 -6,568,000 53,000 3,036,000 -2,598,000 -5,732,000 -1,575,000 2,069,000 -947,000 -1,180,000 
      other assets
    		-306,000 388,000 697,000 -814,000 -1,431,000 -1,154,000 1,024,000 -982,000 580,000 -65,000 1,765,000 6,928,000 469,000 455,000 3,846,000 -956,000 1,056,000 -5,484,000 1,202,000 -11,755,000 -7,329,000 -403,000 161,000 -1,809,000 86,000 -296,000 -833,000 -548,000 
      accounts payable and accrued liabilities
    		3,277,000 -2,736,000 -1,537,000 16,993,000 -4,788,000 -28,265,000 13,240,000 62,014,000 10,065,000 2,626,000 13,886,000                  
      operating lease liabilities
    		-9,196,000 -9,261,000 -9,565,000 -9,086,000 -9,333,000 -8,861,000 -8,835,000 -8,754,000 -7,754,000 -7,548,000 -7,422,000 -7,235,000 -6,398,000 -3,489,000 -3,106,000 13,947,000 3,291,000 -271,000 -2,762,000 -2,519,000 358,000 -2,023,000 -1,858,000      
      deferred revenue
    		-3,610,000 16,686,000 2,427,000 9,065,000 -2,855,000 7,566,000 4,887,000 -1,435,000 9,224,000 -1,911,000 -4,145,000 5,821,000 -1,897,000 6,706,000 -757,000 4,009,000 -1,163,000 120,000 -190,000 1,213,000 -4,148,000 -451,000 -341,000 -818,000 -3,401,000 -617,000 975,000 12,183,000 
      net cash from operating activities
    		-35,413,000 -60,285,000 -62,689,000 -64,513,000 -51,059,000 -94,002,000 -30,284,000 -78,728,000 -77,791,000 -94,015,000 -74,441,000 -90,749,000 -78,160,000 -111,935,000 -28,619,000 -76,988,000 -53,145,000 -62,593,000 -16,291,000 -59,223,000 -8,057,000 -23,365,000 -13,282,000 -30,342,000 1,347,000 -13,836,000 -4,303,000 -26,538,000 
      capex
    		-10,350,000 -5,649,000 -4,459,000 -18,875,000 0 -5,077,000 -5,294,000 -4,077,000 -2,372,000 -6,513,000 -7,524,000 -10,001,000 -21,726,000 -23,034,000 -22,700,000 -697,000 -22,849,000 -18,675,000 -9,586,000 0 -9,786,000 -9,507,000 -9,598,000 0 2,544,000 -3,047,000 -2,705,000 -2,931,000 
      free cash flows
    		-45,763,000 -65,934,000 -67,148,000 -83,388,000 -51,059,000 -99,079,000 -35,578,000 -82,805,000 -80,163,000 -100,528,000 -81,965,000 -100,750,000 -99,886,000 -134,969,000 -51,319,000 -77,685,000 -75,994,000 -81,268,000 -25,877,000 -59,223,000 -17,843,000 -32,872,000 -22,880,000 -30,342,000 3,891,000 -16,883,000 -7,008,000 -29,469,000 
      investing activities:
    		                            
      purchases of marketable debt securities
    		   0                         
      maturities of marketable debt securities
    		0 0 307,323,000 0                         
      sales of marketable equity securities
    		                            
      purchases of non-marketable equity securities
    		-4,000,000                            
      purchases of property and equipment
    		-10,350,000 -5,649,000 -4,459,000 -18,875,000             -22,149,000 -18,675,000 -9,586,000  -9,786,000 -9,507,000 -9,598,000      
      net cash from investing activities
    		-14,350,000 -10,649,000 302,864,000 10,530,000 -294,827,000 -5,077,000 28,066,000 663,454,000 260,699,000 -241,127,000 157,224,000 70,627,000 41,274,000 -72,893,000 110,808,000 -266,697,000 -47,394,000 127,066,000 123,870,000 -297,685,000 -14,656,000 -325,549,000 20,804,000 23,358,000 -35,730,000 -320,527,000 15,329,000 -197,688,000 
      financing activities:
    		                            
      proceeds from issuance of common stock upon exercise of stock options
    		3,721,000 1,557,000 768,000 522,000 20,000 2,364,000 213,000 115,000 70,000 63,000 157,000 120,000 347,000 1,195,000 963,000 1,047,000 1,677,000 926,000 4,462,000 2,129,000 3,851,000 2,044,000 1,504,000 1,844,000 4,265,000 4,992,000 538,000 539,000 
      proceeds from issuances of common stock under employee stock purchase plan
    		0    0    0    0    0    0    3,185,000 0 1,933,000  
      employee taxes paid related to net share settlement of restricted stock units
    		-2,265,000                            
      repurchase of treasury stock
    		0 0 -45,010,000                          
      payment of debt issuance costs
    		0 -151,000 -12,138,000                          
      proceeds from unwinding of convertible note hedges
    		0 0 5,030,000                          
      net cash from financing activities
    		4,331,000 1,624,000 -66,850,000 -2,935,000 -2,885,000 5,898,000 -1,074,000 90,568,000 3,807,000 383,854,000 -854,000 2,318,000 -19,312,000 -172,087,000 -12,000 3,780,000 -5,560,000 4,909,000 -69,953,000 1,046,724,000 797,000 361,320,000 1,466,000 3,077,000 6,871,000 355,068,000 2,288,000 250,364,000 
      net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
    		-533,000 937,000 773,000 -1,695,000 1,900,000 -837,000 -1,138,000 1,030,000 -526,000 -1,252,000 -163,000 1,140,000 -529,000 -1,419,000 -792,000  -113,000 7,000 -1,087,000          
      net increase in cash, cash equivalents and restricted cash
    		-45,965,000 -68,373,000 174,098,000 -58,613,000 -346,871,000 -94,018,000 -4,430,000 676,324,000 186,189,000 47,460,000 81,766,000 -16,664,000 -56,727,000 -358,334,000 81,385,000 -340,405,000 -106,212,000 69,389,000 36,539,000     -3,960,000 -27,465,000 20,864,000 13,245,000 26,165,000 
      cash, cash equivalents and restricted cash—beginning of period
    		0 0 629,755,000  0 0 1,133,687,000   0 141,948,000  0 0 492,288,000              
      cash, cash equivalents and restricted cash—end of period
    		-45,965,000 -68,373,000 803,853,000  -346,871,000 -94,018,000 1,129,257,000   47,460,000 223,714,000  -56,727,000 -358,334,000 573,673,000  -106,212,000 69,389,000 869,516,000          
      reconciliation of cash, cash equivalents and restricted cash:
    		                            
      cash and cash equivalents
    		-49,130,000 -69,429,000 698,572,000 -59,482,000 -348,672,000 -95,333,000 1,029,027,000          -106,220,000            
      restricted cash
    		3,165,000 1,056,000 105,281,000                          
      total cash, cash equivalents and restricted cash
    		-45,965,000 -68,373,000 803,853,000 -58,613,000 -346,871,000 -94,018,000 1,129,257,000          -106,212,000            
      employee taxes paid related to settlement of restricted stock units
    		  -15,497,000                          
      contingent consideration
    		       -120,000 220,000 310,000 -300,000                  
      amortization of debt issuance costs
    		   646,000 645,000 645,000 645,000 644,000 644,000 643,000 644,000  642,000 642,000 642,000  640,000 641,000 641,000          
      amortization of (discount) premium on marketable debt securities
    		       -2,639,000 -7,828,000 -2,076,000 -1,009,000                  
      unrealized and realized losses (gains) on marketable equity securities
    		   -2,824,000                         
      impairment of non-marketable equity securities and other related assets
    		       0 0                    
      fair value adjustments of noncontrolling interest liability
    		           0 0                
      other legal liabilities
    		                            
      sales of marketable equity securities and other related assets
    		                            
      purchases of non-marketable equity securities and other related assets
    		   -5,000,000                         
      proceeds from issuance of common stock under employee stock purchase plan
    		                            
      proceeds from equity offerings
    		                            
      payment of equity offering costs
    		                            
      joint venture acquisition
    		           0 0                
      tender offer issued in connection with the joint venture acquisition and acquisition related costs
    		           1,000                 
      cash, cash equivalents and restricted cash – beginning of period
    		                            
      cash, cash equivalents and restricted cash – end of period
    		                            
      supplemental disclosures of cash flow information:
    		                            
      cash paid for income taxes
    		                       0   -48,000  
      supplemental disclosures of noncash investing and financing activities:
    		                            
      operating lease liabilities arising from obtaining right-of-use assets
    		           0   3,940,000 314,000 157,000 64,000 170,847,000          
      purchases of property and equipment included in accounts payable and accrued liabilities
    		                            
      restricted cash – included in restricted cash
    		                            
      restricted cash – included in other assets
    		                8,000            
      amortization of discount on marketable debt securities
    		                            
      cash effect of changes in operating assets and liabilities:
    		                            
      taxes paid related to net share settlement of restricted stock units
    		    -2,874,000 -3,240,000 -1,544,000 -3,085,000 -3,003,000 -4,116,000 -993,000 -1,359,000 -4,340,000 -1,222,000 -957,000 -1,602,000 -7,199,000 -1,382,000 -73,576,000 -1,200,000         
      proceeds from follow-on public offering
    		        0                    
      payment of offering costs related to follow-on public offering
    		        793,000                    
      restricted cash – included in cash, cash equivalents and restricted cash
    		    1,801,000 1,315,000 100,230,000                      
      amortization of premium (discount) on marketable debt securities
    		     -4,000 111,000     1,229,000                 
      unrealized losses (gains) on marketable equity securities
    		     15,485,000 30,054,000                      
      purchase of marketable debt securities
    		       0 -68,563,000 -498,087,000 -63,252,000 -65,156,000                 
      maturity of marketable debt securities
    		     0 35,000,000 666,000,000 336,000,000 264,700,000 228,000,000 157,000,000                 
      purchase of non-marketable equity securities and other related assets
    		       0 -4,366,000                    
      purchase of property and equipment
    		     -5,077,000 -6,934,000 -4,077,000 -2,372,000 -6,513,000 -7,524,000 -10,001,000 -21,726,000 -23,034,000 -22,700,000           -3,047,000 -2,705,000 -2,931,000 
      purchase of property and equipment included in accounts payable and accrued liabilities
    		      1,640,000                      
      unrealized (gains) losses on marketable equity securities
    		       4,803,000                     
      reclassification of redeemable noncontrolling interest to noncontrolling interest liability
    		                            
      unrealized gains on marketable equity securities
    		         -63,997,000 -3,882,000                  
      payments made on finance lease obligations
    		         -19,000 -18,000 -18,000 -18,000 -17,000 -18,000 -17,000 -38,000 -36,000 -55,000 -49,000         
      purchase of non-marketable equity securities and other related investments
    		            0                
      non-cash operating lease costs
    		           7,191,000 7,197,000 7,248,000 6,949,000 6,879,000 6,943,000 6,907,000 3,932,000 2,218,000         
      charge of in-process research and development costs with no alternative future use
    		                   0 0 0 8,500,000      
      re-valuation of contingent consideration
    		           110,000 390,000 1,415,000 2,390,000 535,000 970,000   0 70,000 0 -190,000      
      amortization of debt discount and debt issuance costs
    		                            
      impairment of other assets
    		           0                 
      credit loss adjustment and others
    		               39,000    -905,000         
      purchase of intangible assets and capitalized license obligations
    		                   0         
      payment of contingent consideration
    		           0                 
      proceeds from public offerings of common stock
    		                            
      payment of offering costs related to public offerings of common stock
    		                            
      proceeds from borrowings on convertible senior notes
    		                            
      payment of offering costs related to borrowings on convertible senior notes
    		               0 0 0 -784,000          
      purchase of convertible note hedges
    		                            
      property and equipment acquired under finance leases
    		               0 2,000            
      vesting of common stock exercised early
    		                            
      debt issuance costs included in accounts payable and accrued liabilities
    		                            
      accounts payable
    		            6,663,000 11,842,000 -753,000 1,699,000 -173,000 -4,874,000 11,986,000 -8,705,000 3,322,000 -11,967,000 9,491,000 3,915,000 -2,987,000 6,023,000 -2,610,000 1,698,000 
      accrued compensation
    		            18,751,000 -17,486,000 13,662,000 3,658,000 4,103,000 -2,445,000 8,900,000 4,243,000 5,511,000 -4,409,000 4,378,000 -6,047,000 10,917,000 -996,000 1,697,000 5,556,000 
      accrued expenses and other liabilities
    		            -1,125,000 7,137,000 8,022,000  3,180,000 2,905,000 4,399,000  306,000    3,429,000    
      purchase of property and equipment included in accounts payable and accrued expenses
    		                            
      issuance costs related to purchase of non-marketable equity and other related investments included in accounts payable and accrued expenses
    		                -241,000            
      amortization of premium (discount) on marketable securities
    		             1,351,000 2,449,000 3,303,000 3,018,000 3,269,000 3,259,000 2,380,000 571,000 485,000 580,000      
      purchase of marketable securities
    		             -74,859,000 -163,742,000           -372,875,000 -45,966,000 -238,757,000 
      maturity of marketable securities
    		             25,000,000 310,000,000 325,000,000 209,000,000 214,000,000 204,110,000 255,000,000 110,000,000 93,500,000 104,048,000 102,269,000 93,904,000 65,160,000 64,000,000 44,000,000 
      purchase of non-marketable equity and other related investments
    		              -12,750,000 -346,000 -26,326,000            
      unrealized translation gains on obligation related to royalty
    		                        -279,000    
      benefit from income tax differences
    		                            
      changes in operating assets and liabilities, net of effect of acquisition:
    		                            
      accrued expenses and other current liabilities
    		                          2,308,000 -255,000 
      business acquisition, net of cash acquired
    		                       0     
      payment in connection with a license agreement
    		                            
      payments made on royalty obligations
    		                        -77,000 -78,000 -73,000  
      net effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
    		                       -53,000 47,000 159,000 -69,000  
      cash paid for interest
    		                       321,000 280,000 287,000 293,000  
      purchases of property and equipment included in accounts payable and accrued expenses
    		               -697,000 -700,000        2,544,000    
      initial fair value of contingent consideration at acquisition date
    		                       0 -70,000    
      debt issuance costs included in accounts payable and accrued expenses
    		                            
      purchases of marketable securities
    		                -207,919,000 -55,509,000 -70,654,000  -114,870,000 -409,542,000 -55,760,000      
      proceeds from public offering, net of underwriting discounts and commissions
    		                    0        
      payment of offering costs related to public offering
    		                    -761,000        
      cash and cash equivalents—beginning of period
    		                0 0 832,977,000          
      follow-on public offering issuance costs included in accounts payable and accrued expenses
    		                            
      deferred rent
    		                        397,000 1,937,000 1,131,000 221,000 
      proceeds from issuance of common stock upon the exercise of warrants
    		                           7,000 
      repurchase of common stock
    		                           0 
      net proceeds from issuance of equity interests in redeemable noncontrolling interest
    		                           0 
      cash and cash equivalents – end of period
    		                            
      deferred offering costs included in accounts payable and accrued expenses
    		                            
      conversion of convertible preferred stock to common stock upon initial public offering
    		                            
      unrealized translation gains (loss) on obligation related to royalty
    		                            
      net effect of foreign exchange rate changes on cash and cash equivalents
    		                    190,000 26,000 23,000      
      amortization of right-of-use assets
    		                     1,890,000 1,496,000      
      others
    		                     -75,000 56,000      
      purchase of intangible assets
    		                     0 -17,886,000      
      payments made on capital lease obligations
    		                     -41,000 -38,000 -49,000 -17,000 -41,000 -21,000 -23,000 
      net increase in cash and cash equivalents
    		                     12,432,000 9,011,000      
      cash and cash equivalents—end of period
    		                            
      accrued expenses
    		                      -660,000      
      other liabilities
    		                      36,000      
      payment of offering costs related to initial public offering and follow-on offering
    		                        -485,000    
      amortization of rou
    		                            
      unrealized translation (gains) losses on obligation related to royalty
    		                          -144,000  
      non-cash interest expense
    		                           -3,000 
      loss on debt extinguishment
    		                            
      long-term operating lease liabilities net of rou
    		                            
      payment related to settlement of debt and buyout of royalty obligations
    		                            
      proceeds from issuance of convertible preferred stock, net of issuance costs
    		                            
      repurchase of convertible preferred stock
    		                            
      cash, cash equivalents and restricted cash - beginning of period
    		                       0 0 0 140,544,000  
      cash, cash equivalents and restricted cash - end of period
    		                       -3,960,000 -27,465,000 20,864,000 153,789,000  
      capitalized license fees financed through future royalty payment
    		                            
      issuance of series d convertible preferred stock in exchange for a technology license agreement
    		                            
      increase in purchases of property and equipment included in accounts payable and accrued expenses
    		                            
      property and equipment acquired under capital leases
    		                            
      amortization of discounts on marketable securities
    		                        -677,000 -723,000 -553,000  
      benefit from income taxes
    		                            
      purchases of intangible assets and capitalized license obligations
    		                            
      proceeds from follow-on offering, net of underwriting discounts and commissions
    		                        0    
      deferred tax assets
    		                            
      business acquisitions, net of cash acquired
    		                            
      payment of offering costs related to initial public offering
    		                          -89,000 -4,165,000 
      proceeds from initial public offering, net of underwriting discounts and commissions
    		                            
      unrealized translation losses on obligation related to royalty
    		                            
      amortization of premium or discounts on marketable securities
    		                            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.